Jump to content

Subacute myelo-optic neuropathy

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Monkbot (talk | contribs) at 05:03, 13 December 2020 (Task 18 (cosmetic): eval 3 templates: del empty params (1×); hyphenate params (2×);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Subacute myelo-optic neuropathy
SpecialtyNeurology

Subacute myelo-optic neuropathy (SMON) is an iatrogenic disease of the nervous system[1] leading to a disabling paralysis, blindness and even death.[2] Its defining manifestation was as an epidemic in Japan during the 1960s: the Japanese government estimated 11,000 were affected; however, the College of Medicine at the University of Tokyo put the number at 30,000, citing a lack of preservation of medical records for longer than five years and a lack of cooperation from doctors as the reasons for the discrepancy.[3] On August 3, 1978, the Tokyo District Court ruled that the cause of SMON is Clioquinol. Its manufacturer, Ciba-Geigy, has publicly stated that "Medical products manufactured and sold by us have been responsible for the occurrence of [SMON] in Japan, we extend our apologies."[3]

SMON was first observed and diagnosed in Sweden 1966, by the pediatrician and neurologist Olle Hansson.[4] Clioquinol was marketed as a prophylaxis to tourist diarrhoea. Dr. Olle Hansson was in the front line, fighting for a ban of clioquinol. Doctors in many countries boycotted Ciba-Geigy for many years. Not until 1985 was the pharmaceutical withdrawn. Dr Hansson died a few months later. The day of his death, May 23, is observed as the Anti-Hazardous Drug Day in several parts of the world.

References

  1. ^ Takasu T (November 2003). "[SMON--a model of the iatrogenic disease]". Rinsho Shinkeigaku. 43 (11): 866–9. PMID 15152488.
  2. ^ Lenzer, Jeanne (2 January 2018). "When a Medical "Cure" Makes Things Much, Much Worse". Smithsonian. Washington, D.C. Retrieved 11 January 2018.
  3. ^ a b Tiranti, Dexter (1 January 1981). "The Devil's Alternative". New Internationalist. Oxford. Retrieved 11 January 2018.
  4. ^ Hansson, Olle: Inside Ciba-Geigy, 1989

Further reading

  • Reisaku Kono, "Relation between Subacute Myelo-Optic Neuropathy (S.M.O.N.) and Clioquinol: Nationwide Survey", The Lancet, V301, I7796, January 27, 1973, pp. 171–173
  • Reisaku Kono, "The S.M.O.N. Virus Theory", The Lancet, V306, I7930, August 23, 1975, pp. 370–371
  • Reisaku Kono, Yoshigoro Kuroiwa, "Subacute Myelo-Optic Neuropathy is not a special form of multiple sclerosis", The Lancet, V320, I8292, July 31, 1982, p. 267
  • Hansson, Olle: "Inside Ciba-Geigy". IOCU 1989. ISBN 967-9973-26-3.


Stub icon

This article about a medical condition affecting the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Subacute_myelo-optic_neuropathy&oldid=993920145"